Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Photochemical Electrocyclic Reactions: Stereochemistry01:26

Photochemical Electrocyclic Reactions: Stereochemistry

1.9K
The absorption of UV–visible light by conjugated systems causes the promotion of an electron from the ground state to the excited state. Consequently, photochemical electrocyclic reactions proceed via the excited-state HOMO rather than the ground-state HOMO. Since the ground- and excited-state HOMOs have different symmetries, the stereochemical outcome of electrocyclic reactions depends on the mode of activation; i.e., thermal or photochemical.
Selection Rules: Photochemical Activation
1.9K
Cycloaddition Reactions: MO Requirements for Photochemical Activation01:12

Cycloaddition Reactions: MO Requirements for Photochemical Activation

2.2K
Some cycloaddition reactions are activated by heat, while others are initiated by light. For example, a [2 + 2] cycloaddition between two ethylene molecules occurs only in the presence of light. It is photochemically allowed but thermally forbidden.
2.2K
Thermal and Photochemical Electrocyclic Reactions: Overview01:26

Thermal and Photochemical Electrocyclic Reactions: Overview

2.5K
Electrocyclic reactions are reversible reactions. They involve an intramolecular cyclization or ring-opening of a conjugated polyene. Shown below are two examples of electrocyclic reactions. In the first reaction, the formation of the cyclic product is favored. In contrast, in the second reaction, ring-opening is favored due to the high ring strain associated with cyclobutene formation.
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The KIF13A-Rab11a axis: a key regulator of vesicle trafficking in cytokinesis.

EXCLI journal·2026
Same author

Restoration of Saccadic Eye Movements and Visually Guided Behavior in Ambient White Light with Photoswitchable Small Molecules.

Journal of the American Chemical Society·2026
Same author

Weather-Resistant Thermoresponsive UV-Curable Smart Window Composites Based on Paraffin Particles.

ACS applied materials & interfaces·2026
Same author

Bimetallic Silver-Gold Nanoplates for Photothermal Antimicrobial Therapy: Integrating High Efficiency with Stable and Multifunctional Design.

ACS applied nano materials·2026
Same author

Photoswitchable COX-2-Selective Inhibitors as Light-Regulated Anti-Inflammatory Agents.

Journal of the American Chemical Society·2026
Same author

Fine-Tuning the SMM Properties of a Bis(ZnDy)-Based Compound by Rationally Reducing/Increasing the Electron Density in the Equatorial Plane Perpendicular to the O<sub>phenoxido</sub>-Dy-O<sub>phenoxido-bridges</sub> Direction.

Inorganic chemistry·2026

Related Experiment Video

Updated: Sep 24, 2025

[DPEPhosbcpCu]PF6: A General and Broadly Applicable Copper-Based Photoredox Catalyst
09:12

[DPEPhosbcpCu]PF6: A General and Broadly Applicable Copper-Based Photoredox Catalyst

Published on: May 21, 2019

9.5K

Synthesis and In Vitro Studies of Photoactivatable Semisquaraine-type Pt(II) Complexes.

Kevin Morales1, Sergi Rodríguez-Calado2, Jordi Hernando1

  • 1Departament de Química, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Spain.

Inorganic Chemistry
|May 6, 2022
PubMed
Summary

New platinum(II) complexes show promise as photoactivatable cancer drugs. These compounds are effective against cisplatin-resistant cells and exhibit a combined mode of action upon photoactivation.

More Related Videos

Cercosporin-Photocatalyzed [4+1]- and [4+2]-Annulations of Azoalkenes Under Mild Conditions
07:12

Cercosporin-Photocatalyzed [4+1]- and [4+2]-Annulations of Azoalkenes Under Mild Conditions

Published on: July 17, 2020

6.4K
Determination of the Photoisomerization Quantum Yield of a Hydrazone Photoswitch
09:33

Determination of the Photoisomerization Quantum Yield of a Hydrazone Photoswitch

Published on: February 7, 2022

3.6K

Related Experiment Videos

Last Updated: Sep 24, 2025

[DPEPhosbcpCu]PF6: A General and Broadly Applicable Copper-Based Photoredox Catalyst
09:12

[DPEPhosbcpCu]PF6: A General and Broadly Applicable Copper-Based Photoredox Catalyst

Published on: May 21, 2019

9.5K
Cercosporin-Photocatalyzed [4+1]- and [4+2]-Annulations of Azoalkenes Under Mild Conditions
07:12

Cercosporin-Photocatalyzed [4+1]- and [4+2]-Annulations of Azoalkenes Under Mild Conditions

Published on: July 17, 2020

6.4K
Determination of the Photoisomerization Quantum Yield of a Hydrazone Photoswitch
09:33

Determination of the Photoisomerization Quantum Yield of a Hydrazone Photoswitch

Published on: February 7, 2022

3.6K

Area of Science:

  • Inorganic Chemistry
  • Medicinal Chemistry
  • Photochemistry

Background:

  • Development of novel platinum(II) complexes for cancer therapy.
  • Addressing cisplatin resistance in cancer cell lines.

Purpose of the Study:

  • Synthesize and characterize new semisquaraine-type Pt(II) complexes.
  • Evaluate their photochemical properties and cytotoxic activity.
  • Investigate their potential as photoactivatable anticancer agents.

Main Methods:

  • Innovative synthesis of eight semisquaraine-type ligands.
  • Comprehensive structural analysis using NMR and X-ray diffraction.
  • Density functional theory calculations for configuration assignment.
  • Photochemical property assessment and photodegradation studies.
  • In vitro cytotoxic activity testing against cancer cell lines, including cisplatin-resistant ones.

Main Results:

  • Successful synthesis and characterization of novel Pt(II) complexes.
  • Identification of photoactive complexes with good solubility in biological media.
  • Demonstration of enhanced cytotoxicity upon photoactivation for complexes C7 and C8.
  • Significant efficacy against cisplatin-resistant cancer cells (HeLa, A2780, A2780cis).
  • Elucidation of a combined mode of action for photoactivated complexes.

Conclusions:

  • Semisquaraine-type Pt(II) complexes C7 and C8 are promising photoactivatable anticancer agents.
  • These complexes overcome cisplatin resistance and exhibit enhanced efficacy upon light activation.
  • The combined mode of action offers a potential therapeutic advantage.